GE HealthCare Technologies Inc. (GEHC) Stock

Healthcare · Medical Devices · Member of S&P 500, NASDAQ 100

GE HealthCare Technologies Inc. (GEHC) closed at USD 68.47 on 2026-10-14, a change of -13.6 % over the past year, with a market capitalization of USD 32B.

GE HealthCare Technologies Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

GE HealthCare Technologies Inc. key figures

Previous close

USD 68.47 (2026-10-14)

1-year change

-13.6 %

Market cap

USD 32B

Enterprise value

USD 40.48B

P/E ratio (trailing)

15.81

P/E ratio (forward)

13.00

EPS (trailing)

4.45

EPS (forward)

5.41

PEG ratio

1.71

Price to book

2.90

Revenue growth

5.8 %

Earnings growth

16.8 %

Dividend per share (trailing)

0.14

Short ratio

5.18

Employees

54,000

Analyst consensus (third-party)

buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company has a strategic collaboration with DeepHealth. GE HealthCare Technologies Inc. was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for GE HealthCare Technologies Inc. and compare it with other stocks.